Type 3 Inositol 1,4,5‐Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma
Pimwipa Ueasilamongkol, Tanaporn Khamphaya, Mateus T. Guerra, Michele A. Rodrigues, Dawidson A. Gomes, Yong Kong, Wei Wei, Dhanpat Jain, David C. Trampert, Meenakshisundaram Ananthanarayanan, Jesus M. Banales, Lewis R. Roberts, Farshad Farshidfar, Michael H. Nathanson, Jittima Weerachayaphorn – 28 June 2019 – Cholangiocarcinoma (CCA) is the second most common malignancy arising in the liver. It carries a poor prognosis, in part because its pathogenesis is not well understood.